The role of the fecal stream in Crohn's disease: An historical and analytic review

Inflammatory Bowel Diseases

Volumn 4, Issue 1, 1998, Pages 29-39

  Janowitz, Henry D ^a,b   Croen, Edward C ^a   Sachar, David B ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Crohn's disease; Fecal stream

Indexed keywords

ANASTOMOSIS; ANIMAL; CROHN DISEASE; DIET THERAPY; FECES INCONTINENCE; HISTORY; HUMAN; ILEOSTOMY; INTESTINE; REVIEW;

ANASTOMOSIS, SURGICAL; ANIMALS; CROHN DISEASE; FECAL INCONTINENCE; HISTORY, 20TH CENTURY; HUMANS; ILEOSTOMY; INTESTINES;

EID: 0031990995     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-199802000-00006     Document Type: Article

References (54)

1. Ginzburg L, Colp R, Sussman M. Ileostomy with exclusion. Ann Surg 1939;110:648-58.
2. Kivel RM, Taylor KB, Oberhelman HA Jr. Response to bypass ileostomy in ulcerative colitis and Crohn's disease of the colon. Lancet 1967;632-6.
3. Oberhelman HA Jr, Kohatsu S, Taylor KB, Kivel RM. Diverting ileostomy in the surgical management of Crohn's disease of the colon. Am J Surg 1968;115:231-9.
4. Howel-Jones J, Lennard-Jones E, Lockhart-Mummery HE. Experience in the treatment of Crohn's disease of the large intestine. Gut 1966;7:448-52.
5. Burman JH, Thompson H, Cooke WT, Alexander-Williams J. The effects of diversion of intestinal contents on the progress of Crohn's disease of the large bowel. Gut 1971;12:11-5.
6. Harper PH, Truelove SC, Lee ECG, Kettlewell MGW, Jewell DP. Split ileostomy and ileocolostomy for Crohn's disease of the colon and ulcerative colitis: a 20 year survey. Gut 1983;24:106-13.
7. Zelas P, Jagelman DG. Loop ileostomy in the management of Crohn's colitis in the debilitated patient. Ann Surg 1980;191: 164-8.
8. McIlrath DC. Diverting ileostomy or colostomy in the management of Crohn's disease of the colon. Arch Surg 1971;103:308-10.
9. Winslet MC, Allan A, Poxon V, Youngs D, Keighley MRB. Faecal diversion for Crohn's colitis: a model to study the role of the faecal stream in the inflammatory process. Gut 1994;35:236-42.
10. Oberhelman HA Jr, Kohatsu S, Taylor KB, Porteous J. Diverting ileostomy for Crohn's disease of the colon, 1970. Fourth World Congress of Gastroenterology, Copenhagen, p. 231.
11. Tytgat GNJ, Mulder CJJ, Brummelkamp WH. Endoscopic lesions in Crohn's disease early after ileocolic resection. Endoscopy 1988; 20:260-2.
12. Rutgeerts P, Goboes K, Peeters M, Hiele M, Penninckx F, Aerts R, Kerremans R, Vantrappen G. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 1991;338:771-4.
13. Sachar DB. Pattern of postoperative recurrence in Crohn's disease. Scand J Gastroenterol 1990;25(suppl 172):35-8.
14. Greenstein AJ, Sachar DB, Pasternack BD, Janowitz HD. Reoperation and recurrence in Crohn's, colitis and ileocolitis. N Engl J Med 1975;293:685-90.
15. Sachar DB, Wolfson DM, Greenstein AJ, Goldberg J, Styczynski R, Janowitz HD. Risk factors for postoperative recurrence of Crohn's disease. Gastroenterology 1983;85:917-21.
16. Nugent FW, Veidenheimer MC, Meissner WA, Haggitt RC. Prognosis after colonie resection for Crohn's disease of the colon. Gastroenterology 1973;65:398-402.
17. Goligher JC. The long-term results of excisional surgery for primary and recurrent Crohn's disease of the large intestine. Dis Colon Rectum 1985;28:51-5.
18. Ho I, Greenstein AJ, Bodian CA, Janowitz HD. Recurrence of Crohn's disease in end ileostomies. Inflammatory Bowel Diseases 1995;1:173-8.
19. Brown JY. The value of complete physiological rest of the large bowel in the treatment of certain ulcerative and obstructive lesions of the organ (with description of operative technique and report of cases). Surg Gyn Obstet 1913;16:610-3.
20. Truelove SC, Ellis H, Webster C. Place of a double-barrelled ileostomy in ulcerative colitis and Crohn's disease: a preliminary report. Br Med J 1965;1:150-3.
21. Janerot G, et al. Collagenous colitis and the fecal stream diversion. Gut 1995;101:449-57.
22. Snapper I, Pompen AWM, Groen J. Ileite regimale. Ann Med Interne 1936;29:5.
23. Cited by Kirsner JB. Historical antecedents of inflammatory bowel concepts. In: Kirsner JB, Shorter RG, ed. Inflammatory bowel disease. Baltimore: Williams & Wilkins, 1995:6.
24. Marion JF, Lachman P, Greenstein AJ, Sachar DB. Rarity of fistulas in Crohn's disease of the jejunum. Inflammatory Bowel Diseases 1995;1:34-6.
25. Harper PH, Lee ECG, Kettlewell MGW, Bennett MK, Jewell DP. Role of the faecal stream in the maintenance of Crohn's colitis. Gut 1985;26:279-84.
26. Winslet MC, Keighley MRB. Faecal challenge as a predictor of the effect of restoring intestinal continuity in defunctioned Crohn's colitis. Gut 1988;29:A1475.
27. Sartor RB. Insight into the pathogenesis of inflammatory bowel diseases by new rodent models of spontaneous colitis. Inflammatory Bowel Diseases 1995;1:64-75.
28. Ursing B, Kamme C. Metronidazole for Crohn's disease. Lancet 1975;1:775-7.
29. Ursing B, Alon T, Bárány F, Bergelin I. et al. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: The Cooperative Crohn's Disease Study in Sweden. Gastroenterology 1982;83:550-62.
30. Sutherland L, Singleton J, Sessions J, et al. Double blind, placebo controlled trial of metronidazole in Crohn's disease. Gut 1991;32: 1071-5.
31. Rutgeerts P, Hiele M, et al. Controlled trial of metronidazole for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995;108:1617-21.
32. Meyers S, Janowitz, HD. "Natural history" of Crohn's disease: an analytic review of the placebo lesson. Gastroenterology 1984;87: 1189-92.
33. Krook A, Lindström B, Kjellander J, Janerot G, Lennert B. Relation between concentrations of metronidazole and Bacteroides species in faeces of patients with Crohn's disease and healthy individuals. J Clin Pathol 1981;34:645-50.
34. Ambrose NS, Allan RN, Keighley MRB, et al. Antibiotic therapy for treatment in relapse of intestinal Crohn's disease: a prospective randomized study. Dis Colon Rectum 1985;28:81-5.
35. Graham DY, Ai-Assi MT, Robinson M. Prolonged remission in Crohn's disease following therapy for mycobacterium paratuberculosis infection. Gastroenterology 1996;108:A826.
36. Rath HC, Bender DE, Holt LC, et al. Metronidazole attenuates colitis in HL-B27/B2 transgenic (TG) rats: a pathologic role for anaerobic bacteria. Clin Immunol Immunopathol 1995;75:S45.
37. Sartor RB. The role of normal enteric bacteria and bacterial products in chronic intestinal inflammation. In: Tytgat GAJ, Bartersman FWM, Van Deventer SJN, eds. Inflammatory bowel disease. Dorbrucht: Klever Arcadian, 1995:519-28.
38. Sartor RB, Roth HC, Selen R. Microbial factors in chronic intestinal inflammation. Curr Opin Gastroenterol 1996;12:327-33.
39. Rath HC, Herforth HH, Ikeda JS, Grunther WB, Hanin TE, Balish E, Taurog JD, Hammer RE, Wilson KH, Sartor RB. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis gastritis, and arthritis in HLA-B27/human microglobulin transgenic rats. J Clin Invest 1996;98:945-53.
40. Taurog JD, Richardson J, Croft J, Simmons WJ, et al. The germ-free state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994;180:2359-64.
41. Wellman W, Fink PC, Denner F, Schmidt SW. Endotoxaemia in active Crohn's disease: treatment with whole gut irrigation and five aminosalicylic acid. Gut 1986;27:814-20.
42. Lennard-Jones JE. Nutrition and special diets. In: Prantera C, Korelitz BI. Crohn's disease. New York: Marcel Dekker, 1996:311-39.
43. King TS, Woolner JT, Hunter JO. Review article: the dietary management of Crohn's disease. Aliment Pharmacol 1997;11:17-31.
44. Locks H, Meryn S, Marosi L, et al. Has total bowel rest a beneficial effect on the treatment of Crohn's disease? Clin Nutr 1983;2:61-4.
45. Greenberg GR, Fleming CR, Jeejeebboy KN, et al. Controlled trial of bowel rest and nutritive support with management of Crohn's disease. Gut 1988;29:1309-15.
46. Middleton SJ, Rucker JD, Kerby GA, et al. Long chain triglycerides adversely affect dietary treatment of active Crohn's disease. Gastroenterohgy 1994;106:A734.
47. Jones V. Comparison of total parenteral nutrition and elemental diet on induction and remission of Crohn's disease. Long-term maintenance of remission by personalized food exclusion diet. Dig Dis Sci 1987;32(suppl):1005-75.
48. Rigaud D, Cerf M, Melchior JC, et al. Nutritional assistance (NA) oral attack of Crohn's disease (CD): efficacy of total parenteral nutrition (TPN), as compared with elimination (EEN) and polymeric (PEN) enterai diets. Gastroenterology 1989;96:A416.
49. Ritchie JK, Wadsworth J, Lennard-Jones JE, et al. Controlled multicentre therapeutic trial of an unrefined carbohydrate, fiber rich diet. BMJ 1987;295:517-20.
50. Gibson GR, Roberfroid MB. Dietary manipulation of the human colon microbiota: introducing the concept of prebiotes. J Nutr 1995;125:1401-12.
51. Rath HC, Ikeda JS, Wilson KH, Sartor RB. Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 rats [Abstract]. Gastroenterology (suppl) [Abstract] 1997;1068.
52. Mayer L, Eisenhardt D. Lack of induction of suppressor cells by intestinal epithelial cells from patients with inflammatory bowel disease. J Clin Invest 1990;86:1255-60.
53. Goebell H, and the IOIBD Task Force on Clinical Trials Drug Trials in Inflammatory Bowel Diseases 1993-1995. A survey conducted by IOIBD. Inflammatory Bowel Diseases 1996;2:265-7.
54. Lashner BA. Consideration of smoking in patients with Crohn's disease. In: Printera C and Korelitz BI, eds. Crohn's disease. New York: Marcel Dekker, 1996:81-91.